Vaxart, Inc. Made Headway
Tue, Jul 07, 2020 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) soared at $8.87, a gain of 37.7%. The stock appeared on our News Catalysts scanner on Tue 07 Jul 20 at 06:56 AM in the 'BIOTECH' category. From Mon 22 Jun 20, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Fri 26 Jun 20 at $14.3 with a volume of 230M+.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- MOGU Inc. (MOGU:NYSE), 104.84%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 80.84%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 43.06%
- Vivint Solar, Inc. (VSLR:NYSE), 38.19%
- Vaxart, Inc. (VXRT:NASDAQ), 37.73%
- Novavax, Inc. (NVAX:NASDAQ), 31.62%
- CTI BioPharma Corp. (CTIC:NASDAQ), 30.25%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 29.69%
- Atento S.A. (ATTO:NYSE), 29.69%
- Fuel Tech, Inc. (FTEK:NASDAQ), 25.12%